ce-spotlight

---------------------------------

The Pharmacist e-Link™ Continuing Education Center is designed to provide you with expanded online access to the highest quality of continuing education on a complimentary basis, through the convenience of the Velocity™ Online Learning Management System.

---------------------------------

---------------------------------

Need Help logging into the Pharmacicst e-Link site?
Click Here for Registration and
Login Information

---------------------------------

banner rdc


	This system allows you to search for relevant content from today’s leading providers in the world of continuing education, maintain your personal curriculum, bank your continuing education credits (both online and offline) track and print your professional transcript and more…

Pharmacist e-Link CE Spotlight

Emerging Trends in HIV Combination Therapy: The Pharmacology and the Pharmacist
The goal of this CE activity is to proactively engage pharmacists dealing with HIV patients to (1) identify the need for boosted protease inhibitors and other combination therapy (2) recognize areas for increased compliance counseling and (3) communicate any necessary compliance challenges to prescribers will enhance therapeutic outcomes in HIV/AIDS patients.
The program is supported by an educational grant from Roche Laboratories.

The Pharmacist's Role in the Medication Therapy Management of Chronic Pain
Managing your patients with chronic pain is critical to ensuring the best patient outcomes. This session will bring you vital information you need to know to give these pharmacy patients the best possible care and greatly improve their quality of life.
This program is supported by an educational grant from Purdue Pharma L.P.

Other Featured CE

Medicare 2006: Pitching Compliance as a Whole New Ballgame
Compliance is all too often an issue in the providing of care to your patients. This informative program will bring you up to speed on just how the Medicare Modernization Act may just help you address this resulting in better care and a better bottom line.
This program is supported by an educational grant from Pfizer Pharmaceuticals.

New Approaches and Patient Counseling in the Treatment of Osteoporosis
Osteoporosis will create a significant problem with severe lifestyle impact to one in two women and one in four men over 50 years of age — many of your pharmacy patients. This program brings you insight to treatment of this patient population.
Commercial Support Provided by Roche Laboratories Inc. and GlaxoSmithKline

Quality Improvement Opportunities in Managing Depression: Measuring Performance Through Benchmarking
The goal of this continuing education activity is to build awareness among physicians and pharmacists of the great burden that depression places on patients, employers, and the healthcare system, and the importance of medication management to improving patient outcomes.
This activity is supported by an educational grant from Wyeth Pharmaceuticals.

Strategies in the Prevention of Cardiovascular Events and Mortality in the High-Risk Older Population
Cardiovascular disease (CVD) is a substantial US healthcare burden, with about 40% of all US deaths annually as a result of cardiovascular events. Current initiatives examine not only pharmacologic treatment, but also lifestyle changes that are focused on the prevention of CVD in the elderly.
This program is supported through an educational grant from Wyeth and King Pharmaceuticals.

Self-Care Management for the Diabetic Patient: Focus on Skin and Nutrition
The goal of this educational activity is to provide an overview of diabetes self-care in the areas of skin care and nutrition. It has been designed for all pharmacists who interact and provide counseling to patients with diabetes.
This program is supported through an educational grant from Health Care Products.

The Health Professional's Role in Formulary Management of Medicare Part D Benefits
Starting January 1, 2006, pharmacists began to experience a multitude of new challenges associated with the new Medicare prescription drug benefit. One of the most time-consuming challenges in the program will be formulary management. Preparation will be key for pharmacists to minimize the economic and humanitarian impact of confused beneficiaries and to limit any delays in care due to this new program.
This program is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.